CONRAD KEMMERLIN SHULER

Allopathic & Osteopathic Physicians|Family Medicine SENECA, SC NPI 1720086705

General Payments — all program years on this page

$1,041.25

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $251.37 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $251.3714

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $127.517
Lilly USA, LLC $30.602
Astellas Pharma US Inc $23.621
Acerta Pharma LLC $22.301
GlaxoSmithKline, LLC. $17.921
Exact Sciences Corporation $14.771
ABBVIE INC. $14.651

By program year

Program yearAmountRecords
2018 $103.086
2019 $307.6814
2020 $56.324
2022 $84.475
2023 $238.3314
2024 $251.3714

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096577695 Novo Nordisk Inc $17.80 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096607425 Novo Nordisk Inc $15.28 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096652294 Novo Nordisk Inc $15.54 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096904483 Novo Nordisk Inc $16.99 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097179359 Novo Nordisk Inc $18.14 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097620490 Novo Nordisk Inc $23.01 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097802976 Novo Nordisk Inc $20.75 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105262786 AstraZeneca Pharmaceuticals LP $22.30 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106094440 ABBVIE INC. $14.65 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114897610 Exact Sciences Corporation $14.77 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116288410 GlaxoSmithKline, LLC. $17.92 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136117291 Lilly USA, LLC $17.37 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136121644 Lilly USA, LLC $13.23 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139359103 Astellas Pharma US Inc $23.62 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.